Carisma Therapeutics Operating Income

Carisma Therapeutics (CARM) currently reports a operating income of $20M as of September 2025. That compares with $-66M in the prior-year period — up 130.4% year over year. Use the charts on this page to explore Carisma Therapeutics's operating income history and peer comparisons.

Carisma Therapeutics's operating income increased from $-66M to $20M — a 130.4% year-over-year increase (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Carisma Therapeutics reported $20M in operating income as of September 2025. That compares with $-66M in the prior-year period — up 130.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $20M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Carisma Therapeutics, and consider following CARM for alerts when major investors trade the stock.

Carisma Therapeutics is classified in the Healthcare sector. On operating income, it currently shows $20M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CARM with unrelated industries.